{
    "laboratory_examinations": [
        {
            "procedure_name": "Bone turnover markers",
            "date": "Not specified",
            "findings": {
                "osteoprotegerin": "< 0.4 pmol/L",
                "RANKL": "9.1 – 23.2 pmol/L",
                "RANKL/OPG ratio": "13 – 33.3",
                "TRAP-5b": "elevated",
                "Osteocalcin": "upper normal range",
                "Deoxypyridinoline (DPD)": "elevated in patient 1 and 2"
            },
            "changes_over_time": "Not specified"
        },
        {
            "procedure_name": "Growth hormone stimulation test",
            "date": "Not specified",
            "findings": {
                "Patient 1": {
                    "maximum GH level": "6.27 ng/ml",
                    "summary": "insufficient growth hormone levels after stimulation"
                },
                "Patient 2": {
                    "maximum GH level": "6.08 ng/ml",
                    "summary": "consistent with growth hormone deficiency"
                },
                "Patient 3": {
                    "IGF-1 level": "Normal",
                    "summary": "did not undergo growth hormone stimulation test"
                }
            },
            "changes_over_time": "Growth hormone therapy resulted in initial catch-up growth in Patient 1 but was discontinued due to low serum levels of IGF-1 and IGFBP-3."
        }
    ]
}